Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01810640 · ClinicalTrials.gov registry record · NA
Pre-recovery Bedside Liver Biopsy in Brain Death Organ Donors
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT01810640 is a NA study that was terminated before completion, run by Rutgers, The State University of New Jersey. The registered enrollment target is 6 participants.
The verdict
NCT01810640, a NA study, was terminated before completion, sponsored by Rutgers, The State University of New Jersey.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study's objective is to obtain preliminary data to test the hypotheses that percutaneous liver biopsy in brain death donors is safe and provides reliable histological information. Furthermore, that information when disseminated fully and widely many hours before organ recovery would not only decrease economic costs of wasteful recovery of livers that are not ultimately transplanted but also increase transplantation and decrease cold ischemia times of recovered livers.
Interventions
- PROCEDURE Percutaneous Liver Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2013-02 |
| Est. Completion | 2015-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01810640
The ClinicalTrials.gov registry entry for NCT01810640 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Percutaneous Liver Biopsy is the first listed.
NCT01810640 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01810640 about?
NCT01810640 is a clinical study titled "Pre-recovery Bedside Liver Biopsy in Brain Death Organ Donors". This study's objective is to obtain preliminary data to test the hypotheses that percutaneous liver biopsy in brain death donors is safe and provides reliable histological information. Furthermore, that information when disseminated fully and widely many hours before organ recovery would not only de...
What is the current status of trial NCT01810640?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2013-02. Estimated completion is 2015-02.
What interventions are being tested in trial NCT01810640?
The interventions under investigation include: Percutaneous Liver Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT01810640?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.